These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 38469735)

  • 1. Comparative transcriptomic analysis reveals differences in gene expression and regulatory pathways between nonacral and acral melanoma in Asian individuals.
    Chiu YJ; Li CY; Wang TH; Ma H; Chou TY
    J Dermatol; 2024 May; 51(5):659-670. PubMed ID: 38469735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C-kit expression of melanocytic neoplasm and association with clinicopathological parameters and anatomic locations in Chinese people.
    Lin YC; Chang YM; Ho JY; Lin HC; Tsai YM; Chiang CP; Wang WM; Gao HW
    Am J Dermatopathol; 2013 Jul; 35(5):569-75. PubMed ID: 23221472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spatial transcriptomic analysis of amelanotic acral melanoma versus pigmented acral melanoma reveals distinct molecular determinants.
    Choi ME; Choi EJ; Lee JH; Won CH; Chang SE; Lee MW; Lee WJ
    Br J Dermatol; 2024 Sep; 191(4):580-591. PubMed ID: 38815138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncogenic signaling pathways and hallmarks of cancer in Korean patients with acral melanoma.
    Moon S; Kim HJ; Lee Y; Lee YJ; Jung S; Lee JS; Hahn SH; Kim K; Roh JY; Nam S
    Comput Biol Med; 2023 Mar; 154():106602. PubMed ID: 36716688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Palbociclib in advanced acral melanoma with genetic aberrations in the cyclin-dependent kinase 4 pathway.
    Mao L; Dai J; Cao Y; Bai X; Sheng X; Chi Z; Cui C; Kong Y; Zhang Y; Wu L; Wang X; Tang B; Lian B; Yan X; Li S; Zhou L; Wei X; Li C; Qi Z; Si L; Guo J
    Eur J Cancer; 2021 May; 148():297-306. PubMed ID: 33770575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic alterations in primary melanoma in Taiwan.
    Sheen YS; Tan KT; Tse KP; Liao YH; Lin MH; Chen JS; Liau JY; Tseng YJ; Lee CH; Hong CH; Liao JB; Chang HT; Chu CY
    Br J Dermatol; 2020 May; 182(5):1205-1213. PubMed ID: 31408190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutational profiling of acral melanomas in Korean populations.
    Shim JH; Shin HT; Park J; Park JH; Lee JH; Yang JM; Kim DH; Jang KT; Lee DY
    Exp Dermatol; 2017 Oct; 26(10):883-888. PubMed ID: 28191690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic and Transcriptomic Analysis Reveals Incremental Disruption of Key Signaling Pathways during Melanoma Evolution.
    Shain AH; Joseph NM; Yu R; Benhamida J; Liu S; Prow T; Ruben B; North J; Pincus L; Yeh I; Judson R; Bastian BC
    Cancer Cell; 2018 Jul; 34(1):45-55.e4. PubMed ID: 29990500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Combined Proteomic and Transcriptomic Signature Is Predictive of Response to Anti-PD-1 Treatment: A Retrospective Study in Metastatic Melanoma Patients.
    Mallardo D; Fordellone M; White A; Vowinckel J; Bailey M; Sparano F; Sorrentino A; Mallardo M; Facchini BA; De Filippi R; Ferrara G; Vanella V; Beeler K; Chiodini P; Cesano A; Warren S; Ascierto PA
    Int J Mol Sci; 2024 Aug; 25(17):. PubMed ID: 39273294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrative Genomic Profiling Uncovers Therapeutic Targets of Acral Melanoma in Asian Populations.
    Shi Q; Liu L; Chen J; Zhang W; Guo W; Wang X; Wang H; Guo S; Yue Q; Ma J; Liu Y; Zhu G; Zhao T; Zhao J; Liu Y; Gao T; Li C
    Clin Cancer Res; 2022 Jun; 28(12):2690-2703. PubMed ID: 35294533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression screening identifies CDCA5 as a potential therapeutic target in acral melanoma.
    Xu T; Ma M; Dai J; Yu S; Wu X; Tang H; Yu J; Yan J; Yu H; Chi Z; Si L; Sheng X; Cui C; Kong Y; Guo J
    Hum Pathol; 2018 May; 75():137-145. PubMed ID: 29452217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct sets of genetic alterations in melanoma.
    Curtin JA; Fridlyand J; Kageshita T; Patel HN; Busam KJ; Kutzner H; Cho KH; Aiba S; Bröcker EB; LeBoit PE; Pinkel D; Bastian BC
    N Engl J Med; 2005 Nov; 353(20):2135-47. PubMed ID: 16291983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic profiling with whole-exome sequencing revealed distinct mutations and novel pathways in Asian melanoma.
    Chiu YJ; Weng HY; Lin YY; Lin YF; Yeh YC; Perng CK; Ma H; Tsai SF; Chou TY
    J Dermatol; 2022 Dec; 49(12):1299-1309. PubMed ID: 36184893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct MAPK and PI3K pathway mutations in different melanoma types in Taiwanese individuals.
    Gao HW; Tsai WC; Perng CL; Wang WM; Chiang CP
    Eur J Dermatol; 2018 Aug; 28(4):509-518. PubMed ID: 30325319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of primary cutaneous melanoma of the hands and feet: a clinicoprognostic study.
    Rex J; Paradelo C; Mangas C; Hilari JM; Fernández-Figueras MT; Ferrándiz C
    Dermatol Surg; 2009 Oct; 35(10):1505-13. PubMed ID: 19686364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ATP-binding cassette transporter ABCB5 gene is expressed with variability in malignant melanoma.
    Vásquez-Moctezuma I; Meraz-Ríos MA; Villanueva-López CG; Magaña M; Martínez-Macias R; Sánchez-González DJ; García-Sierra F; Herrera-González NE
    Actas Dermosifiliogr; 2010 May; 101(4):341-8. PubMed ID: 20487690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy of anti-programmed cell death protein 1 therapy among patients with metastatic acral and metastatic mucosal melanoma.
    Ogata D; Haydu LE; Glitza IC; Patel SP; Tawbi HA; McQuade JL; Diab A; Ekmekcioglu S; Wong MK; Davies MA; Amaria RN
    Cancer Med; 2021 Apr; 10(7):2293-2299. PubMed ID: 33686688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatic inactivating PTPRJ mutations and dysregulated pathways identified in canine malignant melanoma by integrated comparative genomic analysis.
    Hendricks WPD; Zismann V; Sivaprakasam K; Legendre C; Poorman K; Tembe W; Perdigones N; Kiefer J; Liang W; DeLuca V; Stark M; Ruhe A; Froman R; Duesbery NS; Washington M; Aldrich J; Neff MW; Huentelman MJ; Hayward N; Brown K; Thamm D; Post G; Khanna C; Davis B; Breen M; Sekulic A; Trent JM
    PLoS Genet; 2018 Sep; 14(9):e1007589. PubMed ID: 30188888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular and genetic diversity in the metastatic process of melanoma.
    Harbst K; Lauss M; Cirenajwis H; Winter C; Howlin J; Törngren T; Kvist A; Nodin B; Olsson E; Häkkinen J; Jirström K; Staaf J; Lundgren L; Olsson H; Ingvar C; Gruvberger-Saal SK; Saal LH; Jönsson G
    J Pathol; 2014 May; 233(1):39-50. PubMed ID: 24399611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted Genomic Profiling of Acral Melanoma.
    Yeh I; Jorgenson E; Shen L; Xu M; North JP; Shain AH; Reuss D; Wu H; Robinson WA; Olshen A; von Deimling A; Kwok PY; Bastian BC; Asgari MM
    J Natl Cancer Inst; 2019 Oct; 111(10):1068-1077. PubMed ID: 30657954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.